![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Author Correction: Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression
-
Article
Author Correction: Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring
-
Article
Open AccessBlockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer
KRAS mutations are present in over 90% of pancreatic ductal adenocarcinomas (PDAC), and drive their poor outcomes and failure to respond to targeted therapies. Here we show that Leukemia Inhibitory Factor (LIF...
-
Article
Open AccessCell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma
Sebaceous carcinomas (SeC) are cutaneous malignancies that, in rare cases, metastasize and prove fatal. Here we report whole-exome sequencing on 32 SeC, revealing distinct mutational classes that explain both ...
-
Article
Open AccessErratum to: Modeling precision treatment of breast cancer
During the type-setting of the final version of the article [1] some of the additional files were swapped. The correct files are republished in this Erratum.
-
Article
Open AccessCirculating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls
Circulating biomarkers are urgently needed in hepatocellular carcinoma (HCC). The aims of this study were to determine the feasibility of detecting and isolating circulating tumor cells (CTCs) in HCC patients ...
-
Article
Open AccessModeling precision treatment of breast cancer
First-generation molecular profiles for human breast cancers have enabled the identification of features that can predict therapeutic response; however, little is known about how the various data types can bes...
-
Article
Open AccessA robust prognostic signature for hormone-positive node-negative breast cancer
Systemic chemotherapy in the adjuvant setting can cure breast cancer in some patients that would otherwise recur with incurable, metastatic disease. However, since only a fraction of patients would have recurr...
-
Article
Open AccessThe Cancer Genome Atlas Pan-Cancer analysis project
Current clinical practice is organized according to tissue or organ of origin of tumors. Now, The Cancer Genome Atlas (TCGA) Research Network has started to identify genomic and other molecular commonalities a...
-
Article
Timing chromosomal abnormalities using mutation data
-
Article
Timing chromosomal abnormalities using mutation data